http://orcid.org/0000-0001-6584-1183
References
- Choi YM, Kwak MK, Hong SM, et al. Changes in thyroid peroxidase and thyroglobulin antibodies might be associated with Graves' disease relapse after antithyroid drug therapy. Endocrinol Metab. 2019;34(3):268–274.
- Teniente-Serra A, Soldevila B, Quirant-Sánchez B, et al. Distinct pattern of peripheral lymphocyte subsets in Graves' disease with persistency of anti-TSHR autoantibodies. Autoimmunity. 2019;52(5–6):220–227.
- Zha B, Wang L, Liu X, et al. Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease. PLoS One. 2012;7(11):e49835.
- Klatka M, Kaszubowska L, Grywalska E, et al. Treatment of Graves’ disease with methimazole in children alters the proliferation of Treg cells and CD3+ T lymphocytes. Folia Histochem Cytobiol. 2014;52(1):69–77.
- Ding YG, Chen G, Li Q, et al. Frequency of IL-10-producing regulatory B cells associated with disease activity in thyroid-associated orbitopathy. Int J Ophthalmol. 2018;11:1458–1462.
- Li J, Luo Y, Wang X, et al. Regulatory B cells and advances in transplantation. J Leukoc Biol. 2019;105(4):657–668.
- Gu L, Fu B, Sui X, et al. Abnormal expression of B10 cell frequencies: possible relation to pathogenesis and disease severity of aplastic anemia. Rev Assoc Med Bras. 2019;65(5):637–646.
- Germain RN, Huang Y. ILC2s - resident lymphocytes pre-adapted to a specific tissue or migratory effectors that adapt to where they move? Curr Opin Immunol. 2019;56:76–81.
- Ji X, Bie Q, Liu Y, et al. Increased frequencies of nuocytes in peripheral blood from patients with Graves' hyperthyroidism. Int J Clin Exp Pathol. 2014;7(11):7554–7562.
- Zhang M, Wan J, Xu Y, et al. Simultaneously increased expression of glucocorticoid-induced tumor necrosis factor receptor and its ligand contributes to increased interleukin-5/13-producing group 2 innate lymphocytes in murine asthma. Mol Med Rep. 2017;15(6):4291–4299.
- Liu L, Wu L, Gao A, et al. The influence of dihydrotestosterone on the development of Graves' disease in female BALB/c mice. Thyroid. 2016;26(3):449–457.
- Faßbender J, Holthoff HP, Li Z, et al. Therapeutic effects of short cyclic and combined epitope peptides in a long-term model of Graves' disease and orbitopathy. Thyroid. 2019;29(2):258–267.
- Hou X, Zhou J, Yang R, et al. Effect of halofuginone on the pathogenesis of autoimmune thyroid disease in different mice models. Endocr Metab Immune Disord Drug Targets. 2017;17(2):141–148.
- Forsberg MH, Foda B, Serreze DV, et al. Combined congenic mapping and nuclease-based gene targeting for studying allele-specific effects of Tnfrsf9 within the Idd9.3 autoimmune diabetes locus. Sci Rep. 2019;9(1):4316.
- Chen Y, Chen Z, Chong WP, et al. Comparative analysis of the interphotoreceptor retinoid binding protein induced models of experimental autoimmune uveitis in B10.RIII versus C57BL/6 Mice. Curr Mol Med. 2019;18(9):602–611.
- Zhao Q, Jung LK. Frequency of CD19 + CD24hiCD38hi regulatory B cells is decreased in peripheral blood and synovial fluid of patients with juvenile idiopathic arthritis: a preliminary study. Pediatr Rheumatol. 2018;16(1):44.
- Wu Y, Yan Y, Su Z, et al. Enhanced circulating ILC2s and MDSCs may contribute to ensure maintenance of Th2 predominant in patients with lung cancer. Mol Med Rep. 2017;15(6):4374–4381.
- Lu P, Ji X, Wan J, et al. Activity of group 2 innate lymphoid cells is associated with chronic inflammation and dysregulated metabolic homoeostasis in type 2 diabetic nephropathy. Scand J Immunol. 2018;87(2):99–107.
- Bruhn S, Barrenäs F, Mobini R, et al. Increased expression of IRF4 and ETS1 in CD4+ cells from patients with intermittent allergic rhinitis. Allergy. 2012;67(1):33–40.
- Lee MC, Lacey DC, Fleetwood AJ, et al. GM-CSF- and IRF4-dependent signaling can regulate myeloid cell numbers and the macrophage phenotype during inflammation. J Immunol. 2019;202(10):3033–3040.